MYD88 and hepatocellular carcinoma: In the study, we further explore the diagnostic value of lnc-MyD88 in the plasma of HCC patients, especially the differential expression of lnc-MyD88 in the three groups, namely, healthy subjects, LC patients, and HCC patients.